Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.73376 | 31 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68154 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69278 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.74977 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.62883 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74379 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.71987 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.73001 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.38004 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.70805 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66963 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67147 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.67973 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67581 | 30 |